08/05/2026
VetweRx Equine North is participating in a new clinical trial with eQcell
Results from a previous collaborative work showed very positive results. VetweRx’s participation in this study will involve collecting clinical data to help eQcell obtain FDA approval for use of their therapies in the United States. Their stem cells are specifically targeted towards cases where other traditional treatments have been ineffective. Past research shows results in improved lameness scores, strong return-to-work rates, and possible structural joint preservation with no significant adverse reactions.
For this study, the FDA has approved the use of these stem cells for injection of the fetlock joint, carpal joints, stifle joint, tendonitis, and septic joints. Check the original post from VetweRx’s to obtain more information about participation, or contact them directly at (303) 569-4828
🚨VetweRx Equine North is participating in a new clinical trial with eQcell!🚨
2 years ago, we had the opportunity to work with these cells and saw very positive results. We’re excited to continue our partnership with eQcell and can't wait to see how it will benefit our patients and clients. VetweRx’s participation in this study will involve collecting clinical data to help eQcell obtain FDA approval for use of their therapies in the United States. Their stem cells are specifically targeted towards cases where other traditional treatments have been ineffective. Past research shows results in improved lameness scores, strong return-to-work rates, and possible structural joint preservation with no significant adverse reactions.
For this study, the FDA has approved the use of these stem cells for injection of the fetlock joint, carpal joints, stifle joint, tendonitis, and septic joints. To qualify, horses must have a lameness that is isolated to one of these joints or tendons. In cases where there is no improvement at week 6, the patient will qualify for a CT of the treated joint for further evaluation.
If you think your horse may be a good candidate, contact us for more info and to inquire about pricing📞(303) 569-4828
What is eQcell?🧬🥼🧪
eQcell is a regenerative medicine company based at the University of Guelph’s Ontario Veterinary College in Canada. Over the last 20 years of research, eQcell has identified several innovative methods to increase stem cell proliferation and viability for use in regenerative treatments. Their product uses neonatal mesenchymal stromal cells, which are activated using proprietary processes to amplify their therapeutic capacity. eQcell has made its initial introduction in veterinary medicine through several clinical trials in Canada and the USA. While working towards improving treatments in animal health, the company aims to utilize a One Health approach in translating their data over to future use in human medicine. eQcell is a member of the Veterinary Innovation Program (VIP) under FDA’s Center for Veterinary Medicine.
Learn more at www.eqcell.com
